Short Term Immune Response to IL6 inhibition (Tocilizumab)
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
we examined the effects of IL6 inhibition treatment on biologic molecular pathways in a 59 year old patient well diagnosed with RA with inadequate response to DMARD thus treated with tocilizumab. To assess the immunological outcome we used quantitative proteome analysis to evaluate changes in the proteome profile of different biologic pathways in leukocyte cell populations important to RA pathogenesis isolated by positive enrichment of CD14, CD4, CD8, CD19, and CD56.
创建时间：
2016-01-05
